Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques

M Shingai, OK Donau, RJ Plishka… - Journal of Experimental …, 2014 - rupress.org
M Shingai, OK Donau, RJ Plishka, A Buckler-White, JR Mascola, GJ Nabel, MC Nason
Journal of Experimental Medicine, 2014rupress.org
It is widely appreciated that effective human vaccines directed against viral pathogens elicit
neutralizing antibodies (NAbs). The passive transfer of anti–HIV-1 NAbs conferring
sterilizing immunity to macaques has been used to determine the plasma neutralization
titers, which must be present at the time of exposure, to prevent acquisition of SIV/HIV
chimeric virus (SHIV) infections. We administered five recently isolated potent and broadly
acting anti-HIV neutralizing monoclonal antibodies (mAbs) to rhesus macaques and …
It is widely appreciated that effective human vaccines directed against viral pathogens elicit neutralizing antibodies (NAbs). The passive transfer of anti–HIV-1 NAbs conferring sterilizing immunity to macaques has been used to determine the plasma neutralization titers, which must be present at the time of exposure, to prevent acquisition of SIV/HIV chimeric virus (SHIV) infections. We administered five recently isolated potent and broadly acting anti-HIV neutralizing monoclonal antibodies (mAbs) to rhesus macaques and challenged them intrarectally 24 h later with either of two different R5-tropic SHIVs. By combining the results obtained from 60 challenged animals, we determined that the protective neutralization titer in plasma preventing virus infection in 50% of the exposed monkeys was relatively modest (∼1:100) and potentially achievable by vaccination.
rupress.org